Meet Jennifer Petter: Boston startup Arrakis celebrates a big personal transition for top exec
A Boston startup that made this year’s list of promising new biotech ventures to watch is celebrating some personal news about one of its founders today: its chief scientific officer is transgender. Although known as Russ Petter in the past, she now goes by Jennifer Petter.
The company, Arrakis Therapeutics, is stepping forward to warmly applaud her transition, starting first with a blog written by its CEO Michael Gilman and posted to the company website.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.